scAAV5-GRK-HE

N/A

Report date: 2025/01/26 17:58:05

Base Information

Drug NamescAAV5-GRK-HE
Drug Alias NameAAV5 rhodopsin gene therapy (Precision Biosciences/University of North Carolina)
ClassificationBiologics
Mechanisms of ActionRhodopsin stimulants
TargetsRhodopsin
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecision Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina, GreensboroPrecision Biosciences Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A